Biocryst Pharmaceuticals INC (BCRX) — DEFA14A Filings
All DEFA14A filings from Biocryst Pharmaceuticals INC. Browse 3 DEFA14A reports with AI-powered summaries and risk analysis.
DEFA14A Filings (3)
-
BioCryst Pharmaceuticals Files Additional Proxy Materials
— Apr 23, 2026 Risk: low
BioCryst Pharmaceuticals Inc. filed a Definitive Additional Materials (DEFA14A) on April 23, 2026. This filing contains additional soliciting materials related -
BioCryst Pharmaceuticals Files Proxy Materials
— Apr 24, 2025 Risk: low
BioCryst Pharmaceuticals, Inc. filed a Definitive Additional Materials (DEFA14A) on April 24, 2025. This filing is related to their proxy statement and indicate -
Biocryst Pharmaceuticals Files Proxy Materials
— Apr 25, 2024 Risk: low
Biocryst Pharmaceuticals Inc. filed a Definitive Additional Materials proxy statement on April 25, 2024. This filing is related to the company's proxy solicitat
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX